Search Tag: PSP biomarker

2025 14 Oct

  Biomarkers are essential tools in the emergency department for improving early detection, risk stratification, and patient management. This article reviews challenges in biomarker integration, the diagnostic and prognostic value of pancreatic stone protein (PSP), and the role of point-of-care solutions such as the abioSCOPE® in advancing personalised...Read more

2024 02 Oct

  Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its  IVD CAPSULE PSP  test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to accelerate the  Time-to-Detection  of Sepsis. Already certified under the EU IVDR as of July 2022, this FDA clearance marks...Read more